Related Experiment Video
Updated: Jul 8, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Association between hepatitis B surface antibody seropositivity and coronary artery disease
Alireza Amirzadegan1, Gholamreza Davoodi, Mohammad Ali Boroumand
1Tehran Heart Center, Medical Sciences/University of Tehran, Tehran, Iran.
Insights
Hepatitis B surface antibody seropositivity is not linked to coronary artery disease (CAD). This study found no significant correlation between HBV infection markers and CAD development or C-reactive protein levels.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Infectious agents are implicated in coronary atherosclerosis pathogenesis.
- Hepatitis B virus (HBV) infection is prevalent in certain populations.
Purpose of the Study:
- To assess the association between coronary artery disease (CAD) and hepatitis B surface antibody (HBS Ab) seropositivity.
- To investigate the relationship between HBS Ab and C-reactive protein (CRP) levels in subjects undergoing coronary angiography.
Main Methods:
- Cross-sectional study of 830 subjects undergoing coronary angiography.
- HBS Ab status determined by ELISA; CAD assessed angiographically.
- Statistical analysis included Chi-square, t-tests, and Pearson's Correlation Coefficient.
Main Results:
- No significant difference in HBV seropositivity between patients with and without significant CAD (28.7% vs. 28.9%, P=0.954).
- Mean CRP levels did not differ significantly between HBS Ab positive and negative subjects (10.77 vs. 10.33 mg/L, P=0.465).
- CRP levels were significantly higher in the CAD group (P<0.001).
Conclusions:
- Hepatitis B surface antibody seropositivity is not associated with coronary artery disease.
- No significant linear correlation was found between HBS Ab and CRP levels.
- CRP levels are elevated in patients with coronary artery disease, independent of HBV status.
Background:
Specific infectious agents have been found to be related to the pathogenesis of coronary atherosclerosis.
Aims:
We assessed the possible association between angiographically proven coronary artery disease (CAD) and hepatitis B surface antibody (HBS Ab) seropositivity in a population with relatively high prevalence of hepatitis B virus (HBV) infection.
Setting And Design:
This was a cross-sectional study.
Materials And Methods:
We analyzed data from 830 consecutive subjects undergoing coronary angiography, including angiographic results reported by two cardiologists for inter-observer reliability and assessment of HBS Ab status determined by enzyme-linked immunosorbent assay (ELISA).
Statistical Analysis Used:
Chi-square test or Fisher's exact test, independent two-sample t test and the Pearson's Correlation Coefficient test were used, as required. Statistics were performed using SPSS software version 13 (SPSS, Chicago, IL).
Results:
Two hundred forty-nine (30%) subjects had normal angiogram or minimal CAD, and 581 (70%) had significant CAD in at least one major coronary artery. In patients with CAD and in patients without angiographic evidence of significant atherosclerosis, 28.7% and 28.9% respectively were positive for HBV (P=0.954). Mean C-reactive protein levels in subjects with positive and negative HBS Ab were 10.77+/-8.37 mg/L versus 10.33+/-7.64 mg/L respectively (P=0.465). However, C-reactive protein levels in CAD group were significantly higher (P<0.001).
Conclusions:
Our results suggested hepatitis B surface antibody seropositivity has no relationship with coronary artery disease. Moreover, no significant linear correlation exists between HBS Ab and C-reactive protein levels. However, as previously shown, C-reactive protein level in patients with coronary artery disease is significantly higher than in patients with normal coronary arteries.
Related Concept Videos
Hepatitis
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Viral Hepatitis I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations